LANDINI, IDA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.723
EU - Europa 3.521
AS - Asia 1.051
OC - Oceania 41
SA - Sud America 36
AF - Africa 18
Totale 9.390
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.707
PL - Polonia 1.362
RU - Federazione Russa 1.017
HK - Hong Kong 337
SG - Singapore 326
IT - Italia 311
IE - Irlanda 294
SE - Svezia 232
CN - Cina 184
DE - Germania 96
JO - Giordania 65
IN - India 63
FI - Finlandia 54
GB - Regno Unito 44
AU - Australia 40
BR - Brasile 30
CH - Svizzera 23
TR - Turchia 22
UA - Ucraina 18
VN - Vietnam 18
AT - Austria 17
ID - Indonesia 17
BE - Belgio 14
CA - Canada 13
CI - Costa d'Avorio 13
ES - Italia 11
FR - Francia 8
NL - Olanda 7
IQ - Iraq 4
DK - Danimarca 3
MA - Marocco 3
GR - Grecia 2
KR - Corea 2
OM - Oman 2
PE - Perù 2
PH - Filippine 2
PK - Pakistan 2
PT - Portogallo 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AR - Argentina 1
BD - Bangladesh 1
CO - Colombia 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
IL - Israele 1
IR - Iran 1
LT - Lituania 1
MK - Macedonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 9.390
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.358
Warsaw 1.356
Fairfield 445
Chandler 328
Dublin 292
Ashburn 282
Hong Kong 271
Seattle 224
Woodbridge 219
Cambridge 202
Houston 199
Singapore 176
Wilmington 162
Ann Arbor 141
Florence 110
Altamura 85
Lawrence 78
Princeton 69
Beijing 60
Buffalo 51
Boston 43
Bremen 42
Melbourne 40
Boardman 39
Shanghai 39
Mumbai 38
Jacksonville 32
Medford 30
Falls Church 27
New York 27
Moscow 26
Kent 25
Bern 22
San Diego 19
Vienna 17
Jakarta 16
Brussels 14
Abidjan 13
Chennai 13
Helsinki 12
Phoenix 12
Barcelona 11
Council Bluffs 11
Hillsboro 11
Izmir 11
Norwalk 11
Dong Ket 10
London 10
Los Angeles 10
Guangzhou 9
Pune 9
Toronto 9
Dearborn 8
Laurel 5
Redwood City 5
Shenzhen 5
The Dalles 5
Andover 4
Philadelphia 4
Romainville 4
Tappahannock 4
Washington 4
West Jordan 4
Hangzhou 3
Kunming 3
Latina 3
Munich 3
Nanjing 3
Palermo 3
Prato 3
Redmond 3
Sesto Fiorentino 3
Sinalunga 3
São Paulo 3
Turin 3
Wuhan 3
Yubileyny 3
Amman 2
Athens 2
Auburn Hills 2
Bologna 2
Città Di Castello 2
Copenhagen 2
Dallas 2
Falkenstein 2
Fiesole 2
Frankfurt Am Main 2
Guagnano 2
Hefei 2
Huizhou 2
Lima 2
Livorno 2
Muscat 2
Naples 2
Newark 2
Padova 2
Perugia 2
Poggibonsi 2
Radom 2
Radomsko 2
Totale 6.906
Salva come PNG Salva come JPEG
Nome #
In vitro assessment of antibody-conjugated gold nanorods for systemic injections 293
Proteomic Analysis of Ovarian Cancer Cell Responses to Cytotoxic Gold Compounds 291
Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies. 288
Emerging drugs in refractory colorectal cancer 282
Effect of the SOD mimetic MnL4 on in vitro and in vivo oxaliplatin toxicity: Possible aid in chemotherapy induced neuropathy 275
Proteomic analysis of the cytotoxic effects induced by the organogold(III) complex Aubipyc in cisplatin-resistant A2780 ovarian cancer cells: further evidence for the glycolytic pathway implication 263
Proteomic analysis of A2780/S ovarian cancer cell response to the cytotoxic organogold(III) compound Aubipy(c.) 259
The Inhibitory Effects of HYDAMTIQ, a Novel PARP Inhibitor, on Growth in Human Tumor Cell Lines With Defective DNA Damage Response Pathways. 258
Antiproliferative effects of two gold(I)-N-heterocyclic carbene complexes in A2780 human ovarian cancer cells: A comparative proteomic study 253
Druggable Targets in Pancreatic Adenocarcinoma 250
MTHFR-1298 A>C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatin 221
Selection and characterization of a human ovarian cancer cell line resistant to auranofin 206
Replacement of the Thiosugar of Auranofin with Iodide Enhances the Anticancer Potency in a Mouse Model of Ovarian Cancer 170
Epigenetics and chemoresistance in colorectal cancer: An opportunity for treatment tailoring and novel therapeutic strategies 152
A transcriptomic profile predicts clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 148
Exploring the biochemical mechanisms of cytotoxic gold compounds: a proteomic study. 147
Cytotoxic properties of a new organometallic platinum(II) complex and its gold(I) heterobimetallic derivatives. 145
Cellular pharmacology of gemcitabine. 145
RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 143
Chemistry and Biology of Two Novel Gold(I) Carbene Complexes as Prospective Anticancer Agents 142
Gold(III) complexes with 2-substituted pyridines as experimental anticancer agents: Solution behavior, reactions with model proteins, antiproliferative properties 137
Identification Of Pharmacogenomic Markers Of Clinical Efficacy In A Dose-Dense Therapy Regimen (R-Chop14) In Diffuse Large B Cell Lymphoma 135
Fluoropyrimidine-related toxicity in gastrointestinal cancer patients. Assessment of risk factors. 132
Role of Genetic Polymorphisms on Response to R-CHOP regimen in Diffuse Large B-cell Lymphoma Patients: an Interim Analysis of a Multicenter Prospective Pharmacogenetic Study 127
Structural and solution chemistry, protein binding and antiproliferative profiles of gold(I)/(III) complexes bearing the saccharinato ligand. 127
The molecular mechanisms of antimetastatic ruthenium compounds explored through DIGE proteomics 126
Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression 119
Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: an interim analysis of a multicenter prospective pharmacogenetics study. 119
Identification of potential pharmacogenomic markers of clinical efficacy of 5-fluorouracil in colorectal cancer 117
Size dependent biological profiles of PEGylated gold nanorods 116
Pharmacological strategies for overcoming multidrug resistance. 114
In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones. Part I. 113
THE IMPACT OF GENETIC POLYMORPHISMS ON R-CHOP EFFICACY IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: AN INTERIM ANALYSIS OF A MULTICENTER PROSPECTIVE PHARMACOGENETIC STUDY 112
Synthesis, Structural Characterization, Solution Behavior, and in Vitro Antiproliferative Properties of a Series of Gold Complexes with 2-(2'-Pyridyl)benzimidazole as Ligand: Comparisons of Gold(III) versus Gold(I) and Mononuclear versus Binuclear Derivatives 111
Vinorelbine in non-small cell lung cancer: Real-World data from a single institution experience 111
Role of ATP-binding cassette transporters in cancer initiation and progression 110
Erratum: The inhibitory effects of HYDAMTIQ, a novel PARP inhibitor, on growth in human tumor cell lines with defective DNA damage response pathways (Oncology Research 25:9 (1441-1451) DOI: 10.3727/096504017X14926854178616) 110
Structure, solution chemistry, antiproliferative actions and protein binding properties of non-conventional platinum(II) compounds with sulfur and phosphorus donors. 109
Pharmacological modulation of protein kinase C for overcoming drug resistance in colorectal cancer. Preliminary results of in vitro studies. 107
Global gene expression profile reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 106
Pharmacogenomic Markers of Clinical Efficacy in a Dose-Dense Therapy Regimen (R-CHOP14) in Diffuse Large B Cell Lymphoma 104
In vitro study on the safety of near infrared laser therapy in its potential application as postmastectomy lymphedema treatment 102
Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers 100
PNN and KCNQ1OT1 can predict the efficacy of adjuvant fluoropyrimidine-based chemotherapy in colorectal cancer patients 97
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphysms in primary colorectal cancer patients. 96
Identification of pharmacogenomic markers of 5-fluorouracil-based chemotherapy in colorectal cancer 95
Exploratory Genome-Wide Association Analysis to Identify Pharmacogenetic Determinants of Response to R-CHOP in Diffuse Large B-Cell Lymphoma 93
Antiangiogenic Drugs as Chemosensitizers in Cancer Therapy 92
Sequence-dependent interactions between oxaliplatin and 5-fluorouracil in human colon carcinoma cell lines 89
Cyclodextrin Inclusion Complexes of Auranofin and Its Iodido Analog: A Chemical and Biological Study 89
Thymidylate Synthase (TS) mRNA expression and TS gene promoter polymorphism in primary colorectal cancer (CRC) patients (PTS) receiving post-operative fluorouracil (5-FU)-based chemotherapy (CT) 88
Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: an interim analysis of a multicenter prospective pharmacogenetics study. 87
Molecular characterization of established human colorectal carcinoma cell lines (HCT-8) made resistant to 5-fluorouracil (5-FU) by different selective schedules 86
Structure-activity relationships in a series of auranofin analogues showing remarkable antiproliferative properties 86
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphisms in primary colorectal cancer patients 84
Mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1 83
The clinical role of PIK3CA mutations in colorectal cancer 82
In vitro activity of folate antagonists against methotrexate-resistant CCRF-CEM human T-leukemia sublines and relationships with folate pathway gene expression profiles 82
Artificial Intelligence Predictive Models of Response to Cytotoxic Chemotherapy Alone or Combined to Targeted Therapy for Metastatic Colorectal Cancer Patients: A Systematic Review and Meta-Analysis 81
Pharmacogenetics in diffuse large B-cell lymphoma treated with R-CHOP: Still an unmet challenge 81
Pharmacogenomic markers of clinical efficacy in a dose-dense therapy regimen (R-CHOP14) in diffuse large B cell lymphoma: preliminary results 80
Identification of pharmacogenomic markers of 5-fluorouracil-based chemotherapy in colorectal cancer 74
Role of Non-Coding RNAs in Colorectal Cancer: Focus on Long Non-Coding RNAs 72
In vitro activity of folate antagonists against methotrexate-resistant CCRF-CEM human T-leukemia sublines and relationships with folate pathway gene expression profiles 72
Comparative genomic hybridization study of genetic changes associated with 5-fluorouracil resistance in HCT-8 colon cancer cell lines: correlations with the expression profiles 70
Sequence-dependent interactions between oxaliplatin (OHP) and 5-fluorouracil (5-FU) in human colon carcinoma cell lines 62
Mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1 61
Targeting z-Crystallin by aspirin restores the sensitivity to cisplatin in resistant A2780 ovarian cancer cells 58
Preliminary characterization of methotrexate (MTX) resistance mechanisms in human colon carcinoma cells DLD-1 58
Preliminary characterization of methotrexate (MTX) resistance mechanisms in human colon carcinoma cells DLD-1 54
Validation of single nucleotide polymorphisms potentially related to R-CHOP resistance in diffuse large B-cell lymphoma patients 53
Multiple mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1 51
Sequence-dependent interactions between oxaliplatin and 5-fluorouracil in human colon carcinoma cell lines 51
In vitro cell growth inhibitory effects of HYDAMTIQ, a novel PARP inhibitor, on human tumor cell lines with defective DNA damage response pathways 49
P118 A preliminary study for evaluation of cannabis - chemotherapy interactions on human colon cancer cells 48
Multiple mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1. 45
Therapeutic drug monitoring for the cancer patient: challenges and opportunities 42
Effects of reduced extracellular sodium on proliferation and invasive activity of renal cell carcinoma cell lines 25
Role of Non-Coding RNAs in Colorectal Cancer: Focus on Long Non-Coding RNAs 21
null 2
Totale 9.534
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.098
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.098
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020366 0 0 0 0 0 0 0 0 131 100 117 18
2020/2021837 75 74 23 86 70 95 58 57 77 131 49 42
2021/2022511 13 40 39 17 22 28 36 48 30 17 91 130
2022/20231.480 111 265 68 141 114 262 174 84 174 7 31 49
2023/2024617 21 55 79 16 32 67 82 157 15 21 43 29
2024/20253.412 135 361 242 591 1.092 573 48 176 194 0 0 0
Totale 9.534